Reduced
food intake
Acts on appetite pathways that can reduce how much you feel like eating.
Tirzepatide mimics two hormones released after eating. These signals help connect your appetite, digestion, and blood-sugar response.
The two hormones are called GIP and GLP-1. Tirzepatide activates their receptors, including receptors involved in appetite and insulin release. It also slows the movement of food out of the stomach.
Appetite signals
Slower emptying
Insulin response when blood sugar rises
Acts on appetite pathways that can reduce how much you feel like eating.
Delays stomach emptying. This effect is strongest after the first dose and decreases over time.
Increases insulin release and reduces glucagon, a hormone that raises blood sugar, when blood sugar is elevated.
Your physician looks beyond your weight to consider treatment suitability, medication interactions, and how you have responded to previous care.
Share your weight history and any thyroid, pancreatic, gallbladder, or significant digestive conditions.
Include weight-loss medicines, insulin, and oral contraception so your physician can review possible interactions.
Describe previous weight-management treatments, your response, and any side effects that affected you.
Compounded tirzepatide is not FDA-approved. A physician must identify an individual clinical reason for a compounded formulation. Published results for FDA-approved products do not establish results for a compounded product.
Complete the Tirzepatide intake with your medical history and current treatment details. Your physician reviews your responses and contacts you if more information is needed before making a treatment decision.
A free care coordinator call is available for general questions and is not required to begin intake.
Book an Optional Call →